To determine whether the observed metabolic properties following SHP2/MEK inhibition prove true in vivo, we treated KPC mice, monitored the pancreatic tumor volume via magnetic resonance imaging (MRI), and collected tumor interstitial fluid (TIF). Here, MAP2K7 is linked to neoplasm.